drugset / Trial / NCT04507412

Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty

NCT04507412 ↗

Phase 4 Recruiting 74 enrolled Christian Candrian
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to evaluate if intravenous steroid supplementation can provide advantages over routine analgesia protocols in terms of post-operative symptoms (pain and nausea), length of hospital stay, shoulder range of motion, function and patient satisfaction

Timeline

Start
2020-09-09
Primary completion
2032-07-31
Completion
2032-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 9 mg Intravenous

Indications

No indication recorded.